Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 10:11 PM
NCT ID:
NCT01711658
Group ID:
EG001
Title:
IMRT + Cisplatin + Lapatinib
Description:
IMRT: IMRT, 35 fractions over 6 weeks, 6 fractions per week for 5 weeks and 5 fractions per week for 1 week, 2 Gy per fraction to total dose of 70 Gy
Cisplatin: 100 mg/m\^2 administered intravenously on days 8 and 29
Lapatinib: 1500 mg lapatinib by mouth or by feeding tube daily starting 7 days before IMRT for 7 weeks prior to and during IMRT and 3 months after completion of IMRT
Deaths Number Affected:
26
Deaths Number At Risk:
None
Serious Number Affected:
31
Serious Number At Risk:
60
Other Number Affected:
60
Other Number At Risk:
60
Study:
NCT01711658
Results Section:
NCT01711658
Adverse Events Module:
NCT01711658